LONVIA Capital is an independent asset manager with an investment philosophy focused on the long term.

It is based on a unique investment strategy successfully implemented by Cyrille Carrière and his team over many years in European small and mid-cap stocks.

The funds obtained the SRI Label granted by the French State in November 2021, and Article 9 of the SFDR in March 2022.

The company and its partners are committed to devote 10% of net profit to support medical research, social inclusion, and environmental preservation.